The Standard

The Official Blog of Health Level Seven® International

visit HL7.org 

Leading Healthcare Stakeholders Commit to Real-World Testing of HL7’s FHIR Bulk Data Implementation Guide

[fa icon="calendar"] Aug 7, 2019 10:38:22 AM / by Charles Jaffe, MD, PhD

On July 30, as part of the second Blue Button Developers Conference at the White House, a broad coalition of health systems, health plans, and other health IT stakeholders committed to real-world testing of the soon to be published  HL7® FHIR® Bulk Data implementation guide (IG). 

The announcement was made on stage by HL7 International CEO Dr. Charles Jaffe, later joined by Steven Posnack from ONC and Dr. Shafiq Rab of Rush University System for Health. More than 20 early adopters who have committed to advance this important use of HL7 FHIR were identified.

Much of the focus around HL7 FHIR APIs to date has involved  transactions representing  a single patient. While those use cases are important, especially for patients desiring more seamless access to their data via their smartphones, the FHIR Bulk Data Implementation Guide (IG) unleashes FHIR’s potential to revolutionize population health by enabling new services powered by big data. The standardized approach offered by the Bulk Data IG is being used by CMS in its new Data at the Point of Care (DPC) pilot and could help transform the ways healthcare providers and health plans share data for quality improvement and cost accountability.

The Bulk Data IG is the result of a two-year effort funded by ONC’s cooperative agreement with HL7 in partnership with the SMART team at Boston Children’s Hospital/Harvard Medical School.

The following organizations will participate in real-world testing of the HL7 FHIR Bulk Data IG, and Steven noted ONC’s willingness to support these organizations. Participants will collaborate on providing a common set of artifacts, tools and services with an aim to lower standards implementation costs by making them as reusable and transferable as practicable.

Committed organizations include:

ORGANIZATION

NAME

 Anthem Inc.

Sheryl Turney

 BlueCross BlueShield of North Carolina

Joe Bastante and Robert Emerson

 BlueCross BlueShield of South Carolina

Dr. Shawn Stinson

 BlueCross BlueShield of Tennessee

Nick Coussoule and Heather Kennedy

 Boston Children’s Hospital/SMART

Dr. Ken Mandl

 Cambia Health Solutions

Laurent Rotival

CVSHealth (Aetna)

James Murray

 Florida Blue

Amit Shah

 Humana

Heather Cox

 Intermountain Healthcare

Marc Probst

 Jefferson Health

Neil Gomes

 Manifest Medex

Claudia Williams and David Kates

 Marshfield Clinic Health System and Security Health Plan

Dr. Greg Robinson

 Medical University of South Carolina & Health Sciences South Carolina

Dr. Leslie Lenert

 Medigold

Michael Demand

 Mount Sinai Health System (NY)

Mike Berger and Dave Kerwar

 MultiCare Health System and Physicians of Southwest Washington

Melanie Matthews

 OCHIN

Jennifer Stoll

 OrthoVirginia

Terri Ripley

 Oscar Health

Danny Dvinov

 Rush University System for Health

Dr. Shafiq Rab

 Trinity Health

Marcus Shipley and Michael DeBets

 U.S. Department of Veterans Affairs

Dr. Jonathan Nebeker


Signed,

Charles Jaffe, MD, PhD
HL7 International CEO 

 

Steven Posnack, MS, MHS
Executive Director, Office of Technology, ONC

 

 

Topics: FHIR, interoperability, CMS

Charles Jaffe, MD, PhD

Written by Charles Jaffe, MD, PhD

As the Chief Executive Officer of HL7, Dr. Jaffe serves as the organization's global ambassador, fostering relationships with key industry stakeholders. He completed his medical training at Johns Hopkins and Duke Universities, and was a post-doctoral fellow at the National Institutes of Health and at Georgetown University. Over the course of his 40-year career, he has been the principal investigator for more than 200 clinical trials, and has served in various leadership roles in the American Medical Informatics Association. He has been a board member on leading organizations for information technology standards, and served as the chair of a national institutional review board.